Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02695446 · ClinicalTrials.gov registry record · Phase 4
Administration of Oral Extended Release Minocycline for Assessment of Skin and Plasma Concentrations of Minocycline
A Phase 4 study of Acne, sponsored by BioPharmX.
- Completed
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT02695446: Completed Phase 4 study of Acne, sponsored by BioPharmX.
NCT02695446 is a Phase 4 study of Acne that has completed, run by BioPharmX. The registered enrollment target is 12 participants, below the 142-participant average among 26 other Acne trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02695446, a Phase 4 study of Acne, has completed, sponsored by BioPharmX.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to evaluate the skin and plasma concentrations of minocycline in subjects undergoing treatment of acne vulgaris with oral extended release minocycline. Acne lesion counts and safety/tolerance of the treatment will also be evaluated.
Conditions Studied
Interventions
- DRUG Minocycline
Study Locations (1)
Pennsylvania
- KGL Skin Study Center - Broomall
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2016-03 |
| Est. Completion | 2016-05 |
| Phase | Phase 4 |
What the finished NCT02695446 record still lists
NCT02695446 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 142-participant average among 26 other Acne trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Acne appearing as the primary indexed condition, and to 1 intervention - of which Minocycline is the first listed.
NCT02695446 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02695446 about?
NCT02695446 is a clinical study titled "Administration of Oral Extended Release Minocycline for Assessment of Skin and Plasma Concentrations of Minocycline". The primary objective of this study is to evaluate the skin and plasma concentrations of minocycline in subjects undergoing treatment of acne vulgaris with oral extended release minocycline. Acne lesion counts and safety/tolerance of the treatment will also be evaluated.
What is the current status of trial NCT02695446?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2016-03. Estimated completion is 2016-05.
What conditions does trial NCT02695446 study?
This clinical trial studies the following conditions: Acne.
What interventions are being tested in trial NCT02695446?
The interventions under investigation include: Minocycline (DRUG).
Who is sponsoring clinical trial NCT02695446?
This trial is sponsored by BioPharmX, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02695446 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02695446's enrollment target sits among peer trials
12 26th of 26 higher than 1 of 26 other Acne trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acne trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparative Effectiveness Study of Spironolactone Versus Doxycycline for Acne
ACTIVE NOT RECRUITING · Phase 4
-
Analysis of Adherence & Associated Factors in Teenagers Undergoing Treatment of Acne Vulgaris With Differin® Gel 0.1%
COMPLETED · Phase 4
-
A Clinical Trial to Evaluate the Efficacy of Two Acne Treatments
COMPLETED · Phase 4
-
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
COMPLETED · Phase 4
-
Profiling the Skin Microbiome in Response to Altreno in Acne Patients
COMPLETED · Phase 4
-
Comparison Study of Topical Acne Regimens
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia